Latest Insider Transactions at Forte Biosciences, Inc. (FBRX)
This section provides a real-time view of insider transactions for Forte Biosciences, Inc. (FBRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Forte Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Forte Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2023
|
Hubert C Chen Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,593
-34.57%
|
$2,593
$1.01 P/Share
|
|
Apr 01
2023
|
Hubert C Chen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
-
|
|
Apr 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-14.82%
|
$3,241
$1.01 P/Share
|
|
Apr 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+30.01%
|
-
|
|
Apr 01
2023
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
11,046
-0.78%
|
$11,046
$1.01 P/Share
|
|
Apr 01
2023
|
Paul A. Wagner |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+2.17%
|
-
|
|
Dec 16
2022
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
44,024
+3.09%
|
$44,024
$1.07 P/Share
|
|
Dec 15
2022
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
55,976
+4.02%
|
$55,976
$1.03 P/Share
|
|
Sep 07
2021
|
Paul A. Wagner |
SELL
Open market or private sale
|
Direct |
1,000,000
-43.88%
|
$4,000,000
$4.35 P/Share
|
|
Sep 07
2021
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-41.84%
|
$100,000
$4.26 P/Share
|
|
Jan 13
2021
|
Thomas E Darcy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+17.49%
|
$4,500
$9.59 P/Share
|